How Is The Neuralgia Treatment Market Expected To Grow At 6.5% CAGR Over 2025–2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Neuralgia Treatment Market Expected To Grow In Terms Of Size?
The market size for neuralgia treatment has seen robust growth in the past few years. The value of the market is projected to increase from a value of $2.3 billion in 2024 to about $2.43 billion in 2025, growing at a compound annual growth rate (CAGR) of 5.7%. Factors such as an increased incidence of neuralgia, growing awareness about neuropathic pain, a rise in chronic pain conditions, the existence of high disposable income, and government initiatives have fueled the growth during the historic period.
Anticipated robust expansion is predicted for the neuralgia treatment market in the coming years. The market is forecasted to surge to $3.13 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the forecast period encompass an aging demographic, the advent of novel therapies, a rise in diabetes cases, and elevated healthcare spending. Noteworthy trends in this period include progressions in pain management, breakthrough products, digital health amalgamations, and the creation of new drug delivery methods.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12921&type=smp
What Are The Primary Factors Supporting The Neuralgia Treatment Market Expansion?
The increasing incidence of chronic illnesses, including diabetes, is anticipated to boost the expansion of the market for neuralgia treatment. Chronic illnesses are conditions persisting for a year or more, requiring ongoing medical attention, disrupting daily life activities, or both. Diabetes, a long-term metabolic disorder, is marked by elevated blood sugar levels, also known as blood glucose. Neuralgia therapy can address diabetic neuropathy, a type of nerve damage prevalent in diabetic individuals. For instance, the World Health Organization, a specialized United Nations’ agency based in Switzerland, reported in September 2023 that there were 41 million fatalities, accounting for 74% of deaths caused by non-communicable diseases (NCDs) or chronic illnesses globally each year. Therefore, the heightened incidence of chronic illnesses like diabetes is contributing to the growth of the neuralgia treatment market.
Which Segmentation Categories Are Highlighted In The Neuralgia Treatment Market Analysis?
The neuralgia treatmentmarket covered in this report is segmented –
1) By Treatment: Drug Based; Surgeries
2) By Indication: Diabetic Neuropathy; Intercostal Neuralgia; Occipital Neuralgia; Peripheral Neuralgia; Postherpetic Neuralgia
3) By Distribution channels: Drug Stores; Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
4) By End-Use: Hospitals And Clinics; Ambulatory Surgery Centers; Other End-Users
Subsegments:
1) By Drug Based: Anticonvulsants; Antidepressants; Opioids; Topical Treatments; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Surgeries: Nerve Block Procedures; Decompression Surgery; Neurectomy; Spinal Cord Stimulation
Which Notable Trends Are Transforming The Neuralgia Treatment Market Outlook?
Leading corporations in the neuralgia treatment market are placing emphasis on the creation of innovative products and solutions to maintain their market dominance. An example of this occurred in April 2023, when GlaxoSmithKline Pharmaceuticals Ltd., a pharmaceutical firm located in India, introduced Shingrix, the first non-live, recombinant subunit vaccine globally. This vaccine, intended for adults 50 years and over, aims to prevent shingles and post-herpetic neuralgia. Administered in two intramuscular doses, Shingrix merges the antigen glycoprotein E with the AS01B adjuvant system, resulting in a powerful and enduring immune response that can stall the immune system’s degeneration caused by aging. Clinical research suggested that it effectively prevents shingles in adults, with a 97% success rate, and is successful in guarding against post-herpetic neuralgia, a painful shingles complication.
Which Organizations Are At The Forefront Of The Neuralgia Treatment Market?
Major companies operating in the neuralgia treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Horizon Therapeutics, Purdue Pharma, Dr. Reddy’s Laboratories, Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals, Glenmark Pharmaceuticals, Tonix Pharmaceuticals.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Neuralgia Treatment Market?
North America was the largest region in the neuralgia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuralgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12921&type=smp
Browse Through More Reports Similar to the Global Neuralgia Treatment Market 2025, By The Business Research Company
Generic Central Nervous System Drugs Global Market Report 2025
Nerve Repair And Regenerative Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report
Central Nervous System Biomarkers Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
